Effects of octreotide on hepatic glycogenesis in rats with high fat diet-induced obesity

Reduced hepatic glycogenesis is one of the most important causes of metabolic abnormalities in non-alcoholic fatty liver disease. Octreotide, a somatostatin analogue, has been demonstrated to promote weight loss and improve metabolic disorders in mice with high fat diet (HFD)-induced obesity. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiao-Xia, Ye, Ting, Li, Mao, Li, Xian, Qiang, Ou, Tang, Cheng-Wei, Liu, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482138/
https://www.ncbi.nlm.nih.gov/pubmed/28534956
http://dx.doi.org/10.3892/mmr.2017.6586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482138/
https://www.ncbi.nlm.nih.gov/pubmed/28534956
http://dx.doi.org/10.3892/mmr.2017.6586

Ejemplares similares